Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Prepaid Assets (2016 - 2025)

Ani Pharmaceuticals' Prepaid Assets history spans 16 years, with the latest figure at $23.2 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 29.01% year-over-year to $23.2 million; the TTM value through Dec 2025 reached $23.2 million, up 29.01%, while the annual FY2025 figure was $23.2 million, 29.01% up from the prior year.
  • Prepaid Assets for Q4 2025 was $23.2 million at Ani Pharmaceuticals, up from $18.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $23.3 million in Q1 2025 and bottomed at $4.7 million in Q3 2021.
  • The 5-year median for Prepaid Assets is $9.5 million (2022), against an average of $12.0 million.
  • The largest annual shift saw Prepaid Assets dropped 11.03% in 2023 before it soared 133.49% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $7.6 million in 2021, then rose by 10.52% to $8.4 million in 2022, then surged by 107.46% to $17.4 million in 2023, then increased by 3.3% to $18.0 million in 2024, then increased by 29.01% to $23.2 million in 2025.
  • Per Business Quant, the three most recent readings for ANIP's Prepaid Assets are $23.2 million (Q4 2025), $18.6 million (Q3 2025), and $15.1 million (Q2 2025).